Loading…
Friday, July 11, 2014
Current Weather
Loading Current Weather....
HomeNewsMedical
Published: Tuesday, 7/24/2012

Study: Alzheimer's drug fails to slow the disease

BLADE STAFF AND NEWS REPORT

TRENTON, N.J. -- A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the road for the drug.

Pfizer Inc. said Monday that it will continue to study its effect on a different group of patients.

Pfizer, which is testing bapineuzumab with partner Johnson & Johnson, said the injected drug didn't slow mental or functional decline in patients with mild or moderate Alzheimer's disease. The study included about 1,100 patients who carry a gene called ApoE4, which gives people a higher risk of developing the memory-robbing disorder.



Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. If a comment violates these standards or our privacy statement or visitor's agreement, click the "X" in the upper right corner of the comment box to report abuse. To post comments, you must be a Facebook member. To find out more, please visit the FAQ.